A Phase I, Open-label, Randomized, Single-center, 2-way Crossover Food Interaction Study To Assess the Effect of Food on the Pharmacokinetics of the Fixed Dose Combination Capsule of Esomeprazole 20 mg/Acetylsalicylic Acid 81 mg.
Phase of Trial: Phase I
Latest Information Update: 25 Jan 2016
At a glance
- Drugs Aspirin/esomeprazole (Primary)
- Indications Cardiovascular disorders; Embolism and thrombosis; NSAID-induced gastrointestinal damage
- Focus Pharmacokinetics
- 06 Dec 2010 Actual initiation date changed from May 2010 to Jun 2010 as reported by ClinicalTrials.gov.
- 06 Dec 2010 Actual end date changed from Aug 2010 to Sep 2010 as reported by ClinicalTrials.gov.
- 29 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.